Engimata

Designing effective vaccine adjuvants, immuno-stimulatory lipid nanoparticles and drug delivery systems 


We help companies develop vaccines using our patented lipid-based vaccine adjuvant system (L-Vac). If you have a protein based antigen, or nucleic acid, we will provide the liposome or lipid nanoparticle (NLP) for your vaccines R&D.

Our platform enables development of more effective and more stable vaccines across a wide temperature range (-40C to 40C). Please contact us today to find out more.

Affiliations

Sandbox logoSandbox logo
mitvm logomitvm logo
mitinnovationinitiative logomitinnovationinitiative logo
MIT 100K logoMIT 100K logo